| Literature DB >> 30795982 |
Carole Henry1, Nai-Ying Zheng2, Min Huang2, Alexandra Cabanov2, Karla Thatcher Rojas2, Kaval Kaur2, Sarah F Andrews2, Anna-Karin E Palm2, Yao-Qing Chen2, Yang Li3, Katerina Hoskova2, Henry A Utset2, Marcos C Vieira4, Jens Wrammert5, Rafi Ahmed6, Jeanne Holden-Wiltse7, David J Topham8, John J Treanor9, Hildegund C Ertl10, Kenneth E Schmader11, Sarah Cobey4, Florian Krammer12, Scott E Hensley3, Harry Greenberg13, Xiao-Song He13, Patrick C Wilson14.
Abstract
Influenza is a leading cause of death in the elderly, and the vaccine protects only a fraction of this population. A key aspect of antibody-mediated anti-influenza virus immunity is adaptation to antigenically distinct epitopes on emerging strains. We examined factors contributing to reduced influenza vaccine efficacy in the elderly and uncovered a dramatic reduction in the accumulation of de novo immunoglobulin gene somatic mutations upon vaccination. This reduction is associated with a significant decrease in the capacity of antibodies to target the viral glycoprotein, hemagglutinin (HA), and critical protective epitopes surrounding the HA receptor-binding domain. Immune escape by antigenic drift, in which viruses generate mutations in key antigenic epitopes, becomes highly exaggerated. Because of this reduced adaptability, most B cells activated in the elderly cohort target highly conserved but less potent epitopes. Given these findings, vaccines driving immunoglobulin gene somatic hypermutation should be a priority to protect elderly individuals.Entities:
Keywords: elderly population; immunoglobulin genes; influenza vaccine; monoclonal antibodies
Mesh:
Substances:
Year: 2019 PMID: 30795982 PMCID: PMC6452894 DOI: 10.1016/j.chom.2019.01.002
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 21.023